Mesquite, Nevada – Nov 28, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application. UHP continues to advance its Premarket Approval application with the Food and Drug Administration. As described in its October 31 press release, the company has completed its review and documentation […]
News
United Health Products Provides Update on FDA PMA Application
Mesquite, NV, – Oct. 31, 2022 – United Health Products, Inc. (OTCPK: UEEC) (UHP), today provided an update on the company’s FDA Premarket Approval application and financial reporting calendar. As previously disclosed in its press release of September 6th, UHP continues to assemble required documentation and test its manufacturing process to complete its FDA application for […]
United Health Products Announces Equity Financing Agreement and Provides Corporate Update
Mesquite, Nevada – September 6, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today announced that it has entered into a common stock purchase agreement to sell up to $10 million of shares to White Lion Capital, LLC (White Lion), a California-based institutional investor. Under the terms of the purchase agreement, UHP will have the […]
United Health Products Provides Update on FDA Review
Henderson, Nevada – July 15, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application. On July 13 the company and its regulatory consultant met with the full FDA team assigned to review its Class III PMA application. The focus of the meeting was […]
United Health Products Announces Settlement of SEC Investigation
Henderson, Nevada – June 16, 2022 – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021. UHP has agreed with the Securities and Exchange Commission (the Commission) to […]
United Health Products Provides Regulatory Update
Henderson, Nevada – May 18, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process. Regulatory Review As previously disclosed, on April 20, 2022, UHP delivered to the U.S. Food & Drug Administration (FDA) a supplemented and e-formatted Premarket Approval (PMA) response for its HemoStyp™ hemostatic […]